publication of the new recommendations for the injection safe in diabetes
publication of the new recommendations for the safe injection in Diabetes ” has been a formal Protocol for the implementation and maintenance of a culture of safety and a safe working environment for the health professionals caring for patients with diabetes Seville, July 2012.- the WISE consensus Group (Workshop on Injection Safety in Endocrinology) has presented the new recommendations for the safe injection in diabetes. These recommendations are designed to promote the safety of professionals and others with a potential risk of contact with sharps used in the treatment of diabetes. The recommendations have been developed based on the results of an extensive survey carried out 634 nurses from 13 European countries and Russia for 4 months, and the conclusions of the seminar of the Group of consensus in safe injections in Endocrinology – Injection Safety in Endocrinology (WISE), which took place in October 2011 and gathered 58 experts in the field of security in Diabetes. A new European directive on the prevention of injury from sharp short instrumental, published in 2010 and that it must be implemented in all countries members as the deadline in may 2013 provides that when there is risk of injury by sharps, users and health professionals should be protected by adequate security measures, including the use of “medical devices with maximum protection security mechanisms”. Dr. Kenneth Strauss, Global Medical Director, BD, Director of...
Read More